Trials / Completed
CompletedNCT00540059
Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial
Quality Assurance Project in Patients With Advanced Prostate Carcinoma - Evaluation of Tolerability, Quality of Life and Usage of Zoladex 10,8 SafeSystem
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,950 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Purpose of this study is the evaluation of QoL, tolerability and use of Zoladex 10,8 SafeSystem for advanced PCa under naturalistic conditions
Conditions
Timeline
- Start date
- 2005-06-01
- First posted
- 2007-10-05
- Last updated
- 2007-10-05
Source: ClinicalTrials.gov record NCT00540059. Inclusion in this directory is not an endorsement.